Quality Systems Framework

AABB’s new Quality Systems Framework is the next step in the evolution of quality for the blood and biotherapies field, as well as a continuation of our efforts to ensure the highest level of quality and safety for all donors and patients.

AABB asks that our community take the opportunity to review the draft of the Quality Systems Framework and provide feedback by November 22, 2021. If you have any additional questions please contact standards@aabb.org.

View Quality Systems Framework

What’s New? High Level Changes to the 2021 Quality Systems Framework

  • Standards are now written in the active voice.
  • A requirement once stated is not repeated. (Policies, processes, and procedures appear once.)
  • Standardized chapter structure, including:
    • A brief description at the start of each chapter
    • Objective evidence to support implementation
    • Key terms that relate to the content of the chapter
    • Record retention requirements included at the end of each chapter

Why Now?

  • It has been 20 years since the previous update to AABB’s Standards Program.
  • Changes are in response to member needs, as indicated in a Spring 2021 survey.
  • Updates are particularly beneficial to facilities with multiple accreditations (uniformity of language and numbering).
  • Innovative quality systems help to advance the fields of transfusion and biotherapies.
  • Updates to make process easier.
Magali J Fontaine, MD, PhD

“The new AABB quality system essential framework is a unique quality management model that can be applied across any organizational structure that strives for excellence in patient care and continuous education.”

— Magali Fontaine, MD, PhD
University of Maryland School of Medicine

Resources

History of Quality at AABB

Quality concepts have been at the heart of every edition of Standards that AABB has released since 1958 and, in that time, they have evolved from a system of safety and accuracy checks into a quality system that serve as the keystone to the work of transfusion medicine professionals throughout the world.

The most visible step in AABB’s quality evolution occurred in 1997 with the release of Association Bulletin #97-04, (released August 1, 1997), which introduced 10 elements known as the AABB Quality Systems Essentials. These QSEs make up the elements of a quality program, which all AABB-accredited facilities were required to implement by January 1, 1998.

The intent of the quality program as detailed in AB 97-04 was to ensure the consistent application of quality principles to operational areas within an organization. For this reason, AABB began to publish its Standards using the QSEs as chapter headings, with operational activities nested within a quality framework.

Since the quality system essentials were introduced in 1997, the quality language and quality system concepts in AABB Standards have evolved through incremental changes, typically introduced by one set of Standards and then implemented in the others shortly thereafter. For instance, the requirement to collect and evaluate quality indicator data was first introduced in the Standards for Perioperative Autologous Blood Collection and Administration and then subsequently included in all sets of Standards that followed.

Background and Research Conducted

  • Spoke with quality experts in AABB’s community, outside AABB, seasoned quality experts, new quality members, experienced and new members targeted at facilities of varying sizes.
  • Conducted three separate targeted reviews on language and flow.
  • Presented to AABB Standards and Accreditation Program Committees and AABB Board of Directors.
  • Feedback incorporated as needed.
Jeffrey L. Winters, MD

“The new Quality Systems Framework enhances the clarity and usability of AABB Standards by providing a streamlined, uniform structure across all standards.  These changes will enhance understanding and compliance with standards, whether an institution is accredited under one or multiple standard programs, and will serve to further advance quality and patient outcomes.”

— Jeffrey Winters, MD
Mayo Clinic